Vaccine or not vaccine: that’s the question.

Sara Manti, Venera Tiralongo, Carmelo Romeo, Eloisa Gitto

Abstract


In light of the most significant burden of COVID-19 in terms of severe disease and deaths, great progress have been made on the vaccination front with a significant reduction in the severe disease course, rate of hospitalization and deaths, especially in the older population, and also suffering from chronic diseases. Looking at the paediatric population, World Health Organization (WHO) and Food Drug Administration (FDA) are currently reviewing the scientific evidence on the need and timing of vaccinating the paediatric population with the currently available COVID-19 vaccines. Herein, we briefly summarized the impact of COVID-19 on the pediatric population and reported the most recent evidence on the efficacy and safety of COVID-19 vaccination in children

Keywords


children; COVID-19; efficacy; safety; vaccination

Full Text:

PDF

References


1. Ministero della Salute. https://www.governo.it/it/cscovid19/report-vaccini/. Last Access 12 November 2022

2. Shati, A. A., Al-Qahtani, S. M., Alsabaani, A. A., Mahmood, S. E., Alqahtani, Y. A., AlQahtani, K. M., Aldarami, M. S., AlAmri, F. D., Alqahtani, A. S., AlHadi, A. M., Ahmad, A., &Riaz, F. A. (2022). Perceptions of Parents towards COVID-19 Vaccination in Children, Aseer Region, Southwestern Saudi Arabia. Vaccines, 10(8), 1222. https://doi.org/10.3390/vaccines10081222

3. Marziali, E., Lontano, A., Regazzi, L., Paladini, A., Villani, L., Calabrò, G. E., Damiani, G., Laurenti, P., Ricciardi, W., &Cadeddu, C. (2022). Factors Influencing the Choice to Advise for or against COVID-19 Vaccination in the Physicians and Dentists of an Italian Region. Vaccines, 10(11), 1793. https://doi.org/10.3390/vaccines10111793

4. World Health Organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019?adgroupsurvey={adgroupsurvey}&gclid=EAIaIQobChMIlIy34sC6-wIVxQOLCh2UIg8xEAAYASAAEgL30_D_BwE. Last Access: September 28, 2021

5. Perrone, S., Cannavò, L., Manti, S., Rullo, I., Buonocore, G., Esposito, S. M. R., &Gitto, E. (2022). Pediatric Multisystem Syndrome Associated with SARS-CoV-2 (MIS-C): The Interplay of Oxidative Stress and Inflammation. International journal of molecular sciences, 23(21), 12836

https://doi.org/10.3390/ijms232112836

6. Holm, M., Espenhain, L., Glenthøj, J., Schmidt, L. S., Nordly, S. B., Hartling, U. B., &Nygaard, U. (2022). Risk and Phenotype of Multisystem Inflammatory Syndrome in Vaccinated and Unvaccinated Danish Children Before and During the Omicron Wave. JAMA pediatrics, 176(8), 821–823. https://doi.org/10.1001/jamapediatrics.2022.2206

7. Lopez-Leon, S., Wegman-Ostrosky, T., Ayuzo Del Valle, N. C., Perelman, C., Sepulveda, R., Rebolledo, P. A., Cuapio, A., &Villapol, S. (2022). Long-COVID in children and adolescents: a systematic review and meta-analyses. Scientific reports, 12(1), 9950. https://doi.org/10.1038/s41598-022-13495-5

8. Tan, S. H. X., Cook, A. R., Heng, D., Ong, B., Lye, D. C., & Tan, K. B. (2022). Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age. The New England journal of medicine, 387(6), 525–532. https://doi.org/10.1056/NEJMoa2203209

9. Sacco, C., Del Manso, M., Mateo-Urdiales, A., Rota, M. C., Petrone, D., Riccardo, F., Bella, A., Siddu, A., Battilomo, S., Proietti, V., Popoli, P., Menniti Ippolito, F., Palamara, A. T., Brusaferro, S., Rezza, G., Pezzotti, P., Fabiani, M., &Italian National COVID-19 IntegratedSurveillance System and the Italian COVID-19 vaccinesregistry (2022). Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022. Lancet (London, England), 400(10346), 97–103. https://doi.org/10.1016/S0140-6736(22)01185-0

10. Hause, A. M., Shay, D. K., Klein, N. P., Abara, W. E., Baggs, J., Cortese, M. M., Fireman, B., Gee, J., Glanz, J. M., Goddard, K., Hanson, K. E., Hugueley, B., Kenigsberg, T., Kharbanda, E. O., Lewin, B., Lewis, N., Marquez, P., Myers, T., Naleway, A., Nelson, J. C., Shimabukuro, T. T. (2022). Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years. Pediatrics, 150(2), e2022057313.https://doi.org/10.1542/peds.2022-057313

11. World Health Organization https://www.who.int/emergencies/diseases/novel-coronavirus-2019?adgroupsurvey={adgroupsurvey}&gclid=EAIaIQobChMIlIy34sC6-wIVxQOLCh2UIg8xEAAYASAAEgL30_D_BwE. Last Access: 11 August 2022 Statement

FDA. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-bivalent-covid-19-vaccines. Last Access: 19 November, 2022




DOI: https://doi.org/10.13129/1828-6550/APMB.110.2.2022.SD3

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Sara Manti, Venera Tiralongo, Carmelo Romeo, Eloisa Gitto

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.